Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03734029 |
|---|---|
| Brief Title: | Trastuzumab Deruxtecan (DS-8201a) Versus Investigator's Choice for HER2-low Breast Cancer That Has Spread or Cannot be Surgically Removed [DESTINY-Breast04] |
| First Submitted : | November 6, 2018 |
| First Submitted that Met QC Criteria : | November 6, 2018 |
| First Posted : | November 7, 2018 |
| Results First Submitted : | January 11, 2023 |
| Results First Posted with QC Comments : | February 10, 2023 |
| Results First Submitted that Met QC Criteria : | May 25, 2023 |
| Results First Posted : | June 15, 2023 |
| Last Update Submitted that Met QC Criteria : | April 9, 2024 |
| Last Update Posted : | April 11, 2024 |